Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
Abroad (travel likely)RecruitingPHASE2
Conditions
Chemotherapy-induced Peripheral Neuropathy · Drug-Induced Nephropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hammersmith Medicines Research Ltd (HMR code 24-503), London, UK, United Kingdom
Contact: Study coordinator (HMR, Cumberland Avenue London NW10 7EW)
Study leads
Clinical Development
Study Chair
VM Therapeutics LLC